Sterilization Solutions by Market
NovaSterilis offers Supercritical CO2 sterilization services, equipment, and technology tailored to several markets. Supercritical CO2 is an innovative sterilization method that provides an eco-friendly alternative to traditional ethylene oxide (EO) sterilization, achieves a Sterility Assurance Level of 10-6, and is broadly compatible with a range of materials.
The regenerative medicine industry is an ever-expanding market, and the need for gentle, effective sterilization methods is essential. NovaSterilis’ scCO2 technology and equipment platforms are broadly compatible and can sterilize, clean, and decellularize a variety of biomaterials.
Supercritical CO2 offers an effective terminal sterilization solution for even the most complex medical devices and is effective for materials that are temperature and chemically sensitive. NovaSterilis offers contract sterilization services and in-house processing equipment for the medical device industry.
Innovation in additive manufacturing means that biomaterial suppliers will need to sterilize their specialty materials, and device manufacturers will need to sterilize their final products. NovaSterilis offers technology to terminally sterilize complex and sensitive devices as well as a proof-of-concept testing program that enables R&D teams to assess compatibility with scCO2.
Traditional sterilization methods have long been incompatible with biotherapeutics. Supercritical CO2 offers an alternative solution with a variety of applications for the pharmaceutical industry including sterilization, extraction, and impregnation of bioactives.
A growing number of drug-delivery devices and combination products containing natural and synthetic materials used in medicine require a sterilization solution that maintains the material’s physical characteristics and biological qualities. NovaSterilis’ scCO2 sterilization process can sterilize innovative regenerative materials with minimal functional effects on the devices.
NovaSterilis has supported academic and industry R&D groups for years, bringing extensive experience and expertise in the use of scCO2. When bringing a product to market, it’s vital to consider sterilization methods early on in the R&D process. NovaSterilis offers R&D equipment, Commercial Equipment, and Contract Research Services to help partners take full advantage of scCO2 sterilization and processing capabilities.